Pharmaceuticals Ultrasector Profund Fund Technical Analysis

PHPSX Fund  USD 23.10  0.24  1.05%   
As of the 25th of November, Pharmaceuticals Ultrasector holds the Coefficient Of Variation of 1106.93, semi deviation of 1.5, and Risk Adjusted Performance of 0.0745. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharmaceuticals Ultrasector, as well as the relationship between them.

Pharmaceuticals Ultrasector Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Pharmaceuticals, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Pharmaceuticals
  
Pharmaceuticals Ultrasector's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Pharmaceuticals Ultrasector technical mutual fund analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, fund market cycles, or different charting patterns.
A focus of Pharmaceuticals Ultrasector technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Pharmaceuticals Ultrasector trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Pharmaceuticals Ultrasector Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Pharmaceuticals Ultrasector volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Pharmaceuticals Ultrasector Trend Analysis

Use this graph to draw trend lines for Pharmaceuticals Ultrasector Profund. You can use it to identify possible trend reversals for Pharmaceuticals Ultrasector as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Pharmaceuticals Ultrasector price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Pharmaceuticals Ultrasector Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Pharmaceuticals Ultrasector Profund applied against its price change over selected period. The best fit line has a slop of   0.04  , which means Pharmaceuticals Ultrasector Profund will continue generating value for investors. It has 122 observation points and a regression sum of squares at 56.8, which is the sum of squared deviations for the predicted Pharmaceuticals Ultrasector price change compared to its average price change.

About Pharmaceuticals Ultrasector Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Pharmaceuticals Ultrasector Profund on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Pharmaceuticals Ultrasector Profund based on its technical analysis. In general, a bottom-up approach, as applied to this mutual fund, focuses on Pharmaceuticals Ultrasector price pattern first instead of the macroeconomic environment surrounding Pharmaceuticals Ultrasector. By analyzing Pharmaceuticals Ultrasector's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Pharmaceuticals Ultrasector's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Pharmaceuticals Ultrasector specific price patterns or momentum indicators. Please read more on our technical analysis page.

Pharmaceuticals Ultrasector November 25, 2024 Technical Indicators

Most technical analysis of Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pharmaceuticals from various momentum indicators to cycle indicators. When you analyze Pharmaceuticals charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Pharmaceuticals Ultrasector One Year Return

Based on the recorded statements, Pharmaceuticals Ultrasector Profund has an One Year Return of 30.9382%. This is 40.74% lower than that of the ProFunds family and 44.98% lower than that of the Trading--Leveraged Equity category. The one year return for all United States funds is notably lower than that of the firm.
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.

Other Information on Investing in Pharmaceuticals Mutual Fund

Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Managers
Screen money managers from public funds and ETFs managed around the world